various developments during the year
2019年1月14日 ペットOver the last decade, we have seen a steady stream of biosimilars being launched in India, which augurs well for patients.ThePrint’s YouTube channel is now active and buzzing.Insurance Cover for Mental IllnessAnother big stride forward in healthcare in India this year was the Insurance Regulatory and Development Authority of India’s (IRDA) directive asking insurance companies to provide coverage for mental illness.
India’s Biocon is a recognised front runner in this emerging opportunity with a large pipeline of Biosimilars both under development and in global markets.This feat not only speaks volumes of the kind of medical talent we have in our country but also offers hope to women born without a uterus and those with a non-functional uterus.The Budget announcement earlier this year of the government’s intention to set up 24 new government medical colleges and hospitals by upgrading existing district hospitals in the country is also noteworthy.Initial reports on the performance of this program are encouraging.
In the 10 weeks since it was unveiled in September, nearly 500,000 people have availed the benefits of PMJAY, for which over Rs 700 crore has been authorised, according to the government.Government-funded Universal Health InsuranceThis year, the NDA government rolled out the ambitious Ayushman Bharat program, which envisages a two-pronged Cable Shielding Material Manufacturers approach to provide universal access to primary, secondary and tertiary healthcare to nearly 40% of India’s population. According to the National Mental Health Survey of India 2015-16, families spent nearly Rs 1,000-1,500 a month on average for treatment, with the entire expenses coming out of the pocket. Non-insured persons will now be able to avail medical services from underutilized ESIC hospitals at subsidised rates.The article was first published here.5 lakh more health centres under Ayushman Bharat by 2023Putting the Spotlight on NCDsThe proposal to set up 150,000 health and wellness centres in India by 2022 under.
Aysuhman Bharat is timely, given the looming threat from non-communicable diseases . One part of it focuses on providing comprehensive primary care at the community level, while the other aims at providing cashless health insurance cover up to Rs 500,000 per family annually to 100 million poor and vulnerable families through a network of empanelled hospitals under the Pradhan Mantri Jan Arogya Yojana. The aim going ahead should be to ensure ‘best-in-class’ healthcare services delivery in the public and private sphere for the larger benefit of Indian patients. This is a significant development as one in five Indians face depression in their lifetime, according to the World Health Organization.More Hospital Beds to Become Available for the Common ManThe government has recently decided to open up hundreds of hospitals running under the Employees State Insurance Corporation (ESIC) to the general public.Also read: ‘Expensive’ cardiac treatment tops Ayushman Bharat list in first 90 days‘Made in India’ Biosimilars Make it to Developed MarketsThe Indian pharmaceutical industry has stepped up its efforts in developing biosimilars, as a class of generic biopharmaceuticals that provide affordable access to key life saving drugs.14Shares. As most of these conditions can be addressed at the primary level if identified early and managed appropriately, HWCs have a key role to play in the fight against NCDs. The application of technology will enable surveillance, monitoring and evaluation of the health status of the population and improve the quality of healthcare interventions.The launch of the govt’s flagship programme Ayushman Bharat & other developments gave a booster shot to India’s healthcare in 2018.The labour ministry-run ESIC has over 150 hospitals and 1,500 dispensaries across India currently catering to the healthcare need of industrial workers who are subscribers of the corporation.Writer Kiran Mazumdar Shaw is an investor of ThePrint. These developments could well determine the ‘health’ of India’s development story in the years ahead and thus need to be followed closely. This is especially true of India where over 60% of the population pay healthcare and hospitalization expenses from their own pockets as they aren’t covered under any health protection scheme. Its impact on employment generation is already evident.It is heartening to see the government adopting a technology-based approach to ensure the success of the Comprehensive Primary Healthcare NCD program under Ayushman Bharat. This was the twelfth baby in the world to be born through a uterus transplant and the first in all of Asia.Besides ensuring that a large number of Indians have adequate health protection, this scheme can create much-needed jobs.ConclusionThe various developments during the year are definitely promising, but we cannot allow the momentum to slip. The Naukri JobSpeak Index recorded a 34% year-on-year increase for the healthcare industry in November 2018. Several Indian companies have also initiated efforts in this direction. According to newspaper reports, the ESIC will initially run a pilot and based on the outcome and experience in the first year, the move will become permanent.Private healthcare providers seem to have responded enthusiastically to PMJAY.
India’s Biocon is a recognised front runner in this emerging opportunity with a large pipeline of Biosimilars both under development and in global markets.This feat not only speaks volumes of the kind of medical talent we have in our country but also offers hope to women born without a uterus and those with a non-functional uterus.The Budget announcement earlier this year of the government’s intention to set up 24 new government medical colleges and hospitals by upgrading existing district hospitals in the country is also noteworthy.Initial reports on the performance of this program are encouraging.
In the 10 weeks since it was unveiled in September, nearly 500,000 people have availed the benefits of PMJAY, for which over Rs 700 crore has been authorised, according to the government.Government-funded Universal Health InsuranceThis year, the NDA government rolled out the ambitious Ayushman Bharat program, which envisages a two-pronged Cable Shielding Material Manufacturers approach to provide universal access to primary, secondary and tertiary healthcare to nearly 40% of India’s population. According to the National Mental Health Survey of India 2015-16, families spent nearly Rs 1,000-1,500 a month on average for treatment, with the entire expenses coming out of the pocket. Non-insured persons will now be able to avail medical services from underutilized ESIC hospitals at subsidised rates.The article was first published here.5 lakh more health centres under Ayushman Bharat by 2023Putting the Spotlight on NCDsThe proposal to set up 150,000 health and wellness centres in India by 2022 under.
Aysuhman Bharat is timely, given the looming threat from non-communicable diseases . One part of it focuses on providing comprehensive primary care at the community level, while the other aims at providing cashless health insurance cover up to Rs 500,000 per family annually to 100 million poor and vulnerable families through a network of empanelled hospitals under the Pradhan Mantri Jan Arogya Yojana. The aim going ahead should be to ensure ‘best-in-class’ healthcare services delivery in the public and private sphere for the larger benefit of Indian patients. This is a significant development as one in five Indians face depression in their lifetime, according to the World Health Organization.More Hospital Beds to Become Available for the Common ManThe government has recently decided to open up hundreds of hospitals running under the Employees State Insurance Corporation (ESIC) to the general public.Also read: ‘Expensive’ cardiac treatment tops Ayushman Bharat list in first 90 days‘Made in India’ Biosimilars Make it to Developed MarketsThe Indian pharmaceutical industry has stepped up its efforts in developing biosimilars, as a class of generic biopharmaceuticals that provide affordable access to key life saving drugs.14Shares. As most of these conditions can be addressed at the primary level if identified early and managed appropriately, HWCs have a key role to play in the fight against NCDs. The application of technology will enable surveillance, monitoring and evaluation of the health status of the population and improve the quality of healthcare interventions.The launch of the govt’s flagship programme Ayushman Bharat & other developments gave a booster shot to India’s healthcare in 2018.The labour ministry-run ESIC has over 150 hospitals and 1,500 dispensaries across India currently catering to the healthcare need of industrial workers who are subscribers of the corporation.Writer Kiran Mazumdar Shaw is an investor of ThePrint. These developments could well determine the ‘health’ of India’s development story in the years ahead and thus need to be followed closely. This is especially true of India where over 60% of the population pay healthcare and hospitalization expenses from their own pockets as they aren’t covered under any health protection scheme. Its impact on employment generation is already evident.It is heartening to see the government adopting a technology-based approach to ensure the success of the Comprehensive Primary Healthcare NCD program under Ayushman Bharat. This was the twelfth baby in the world to be born through a uterus transplant and the first in all of Asia.Besides ensuring that a large number of Indians have adequate health protection, this scheme can create much-needed jobs.ConclusionThe various developments during the year are definitely promising, but we cannot allow the momentum to slip. The Naukri JobSpeak Index recorded a 34% year-on-year increase for the healthcare industry in November 2018. Several Indian companies have also initiated efforts in this direction. According to newspaper reports, the ESIC will initially run a pilot and based on the outcome and experience in the first year, the move will become permanent.Private healthcare providers seem to have responded enthusiastically to PMJAY.
コメント